SGRX on Nasdaq
SANGRIX INC.
SANGRIX INC. is a finance services company in the Cayman Islands, listed on Nasdaq (SGRX).1
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with STRATEGIC ACQUISITIONS INC /NV/, T-REX Acquisition Corp. or Universal Token, or pick any stock.
- TickerSGRX on Nasdaq1
- IndustryFinance Services1
- HeadquartersE91
- Incorporated inCayman Islands3
- Business address160 Robinson Road, 12F, Sbf Center, Singapore, 0689143
- Filer categoryNon-accelerated filer3
- Legal formCorporation
See how the biggest companies compare on our leaderboards
SonicHash Canada was formed on December 14, 2021 under the laws of Alberta, Canada. It is a subsidiary of SANGRIX. It is not currently engaging in any active business as of the date of this annual report.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Other costs100¢$39.5K
Out of $39.5K in revenue.2 The company lost money this year.
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 3 fiscal years, latest first.2
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Total revenues | $39.5K | $2.9M | |
| Total cost of revenues | $3.8M | ||
| GROSS PROFIT / (LOSS) | $39.5K | -$945.2K | |
| General and administrative | $2.8M | $3.1M | $3.8M |
| Provision for / (recovery of) credit losses | $603.8K | -$51.6K | $1.1M |
| Change in fair value of crypto assets | $10.9M | ||
| Impairment loss of crypto assets | $7.1K | ||
| Impairment loss of miners | $0 | $0 | $6.5M |
| Impairment loss of long-term investment | $2.4M | ||
| Share based compensation expense | $73.2K | ||
| Total operating expenses | $14.3M | $3.0M | $13.9M |
| LOSS FROM OPERATIONS | -$14.3M | -$3.0M | -$14.8M |
| Realized gain on sale/exchange of crypto assets | $247.6K | $94.1K | |
| Interest income | $210.0K | $210.0K | $97.9K |
| Interest expense | -$665.2K | -$595.7K | |
| Other financing expenses | -$1.1M | -$1.2M | -$1.1M |
| Loss on warrants settlement | -$1.9M | ||
| Change in fair value of convertible debentures | $902.1K | ||
| Total other expenses, net | -$13.9K | -$1.4M | -$3.4M |
| LOSS BEFORE INCOME TAXES | -$14.3M | -$4.4M | -$18.3M |
| NET LOSS | -$14.3M | -$4.4M | -$18.3M |
| LESS: Net (loss) / income attributable to noncontrolling interests | -$7.7K | $17.3K | -$753.3K |
| Deemed dividend attributable to down round feature of warrants | $9.6M | $2.1M | |
| NET LOSS ATTRIBUTABLE TO SANGRIX INC. | -$23.9M | -$6.5M | -$17.5M |
| Effects of credit risk change from liabilities measured at fair value | $333.0K | ||
| Reclassification of change in instrument-specific credit risk | $147.0K | ||
| LESS: Total comprehensive (loss) / income attributable to noncontrolling interests | -$7.7K | $17.3K | -$753.3K |
| TOTAL COMPREHENSIVE LOSS ATTRIBUTABLE TO SANGRIX INC. | -$13.8M | -$4.4M | -$17.5M |
| WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES - BASIC (in shares) | 339.7K shares | 77.0K shares | 17.5K shares |
| WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES - DILUTED (in shares) | 339.7K shares | 77.0K shares | 17.5K shares |
| LOSS PER SHARE - BASIC | -$70.43 | -$84.84 | -$1,003.41 |
| LOSS PER SHARE - DILUTED | -$70.43 | -$84.84 | -$1,003.41 |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 5 fiscal years (annual) or 8 quarters (quarterly), latest first.2
| Period ending | 2026-08-31 | 2026-06-30 | 2026-01-31 | 2025-07-31 | 2025-06-30 |
|---|---|---|---|---|---|
| Cash and cash equivalents | $1.6M | $55.6K | |||
| Crypto assets | $5.1M | ||||
| Other receivables, net | $544.0K | $1.0M | |||
| Prepayments, net | $351.8K | $555.0K | |||
| Loans receivable, net | $2.6M | $1.9M | |||
| Total current assets | $10.2M | $3.5M | |||
| Loans receivable, net | $10.8M | ||||
| Deposit for long-term investment | $200.0K | ||||
| Total noncurrent assets | $11.0M | ||||
| Total assets | $21.2M | $3.5M | |||
| Other payables and accrued liabilities | $1.5M | $372.1K | |||
| Total current liabilities | $1.5M | $372.1K | |||
| Convertible debentures | $10.6M | ||||
| Total noncurrent liabilities | $10.6M | ||||
| Total liabilities | $12.1M | $372.1K | |||
| Class A Ordinary Shares subject to potential redemption, 66,668 and nil shares issued and outstanding as of June 30, 2026 and 2025, respectively | $4.2M | ||||
| Additional paid-in capital | $117.3M | $92.2M | |||
| Accumulated deficit | -$112.2M | -$88.3M | |||
| Other comprehensive income | $480.0K | ||||
| Total SANGRIX INC. shareholders' equity | $5.6M | $3.9M | |||
| NONCONTROLLING INTERESTS | -$743.5K | -$735.8K | |||
| Total shareholders' equity | $4.9M | $3.2M | |||
| Total liabilities, mezzanine equity and shareholders' equity | $21.2M | $3.5M | |||
| Shares issued (in shares) | 66.7K shares | 0 shares | |||
| Shares outstanding | 66.7K shares | 0 shares | |||
| Ordinary shares, par value (in dollars per share) | $0.00 | ||||
| Reverse share split | 0 pure | 0 pure |
| Period ending | 2026-08-31 | 2026-06-30 | 2026-01-31 | 2025-07-31 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2023-05-31 |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | $1.6M | $55.6K | ||||||
| Crypto assets | $5.1M | |||||||
| Other receivables, net | $544.0K | $1.0M | ||||||
| Prepayments, net | $351.8K | $555.0K | ||||||
| Loans receivable, net | $2.6M | $1.9M | ||||||
| Total current assets | $10.2M | $3.5M | ||||||
| Loans receivable, net | $10.8M | |||||||
| Deposit for long-term investment | $200.0K | |||||||
| Total noncurrent assets | $11.0M | |||||||
| Total assets | $21.2M | $3.5M | ||||||
| Other payables and accrued liabilities | $1.5M | $372.1K | ||||||
| Total current liabilities | $1.5M | $372.1K | ||||||
| Convertible debentures | $10.6M | |||||||
| Total noncurrent liabilities | $10.6M | |||||||
| Total liabilities | $12.1M | $372.1K | ||||||
| Class A Ordinary Shares subject to potential redemption, 66,668 and nil shares issued and outstanding as of June 30, 2026 and 2025, respectively | $4.2M | |||||||
| Additional paid-in capital | $117.3M | $92.2M | ||||||
| Accumulated deficit | -$112.2M | -$88.3M | ||||||
| Other comprehensive income | $480.0K | |||||||
| Total SANGRIX INC. shareholders' equity | $5.6M | $3.9M | ||||||
| NONCONTROLLING INTERESTS | -$743.5K | -$735.8K | ||||||
| Total shareholders' equity | $4.9M | $3.2M | $909.6K | $10.3M | ||||
| Total liabilities, mezzanine equity and shareholders' equity | $21.2M | $3.5M | ||||||
| Shares issued (in shares) | 66.7K shares | 0 shares | ||||||
| Shares outstanding | 66.7K shares | 0 shares | ||||||
| Ordinary shares, par value (in dollars per share) | $0.00 | |||||||
| Reverse share split | 0 pure | 0 pure | 1 pure |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.2
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Net loss | -$14.3M | -$4.4M | -$18.3M |
| Depreciation | $900.9K | ||
| Provision for (recovery of) credit losses | $603.8K | -$51.6K | $1.1M |
| Realized gain on sale/exchange of crypto assets | -$247.6K | -$94.1K | |
| Change in fair value of crypto assets | $10.9M | ||
| Impairment loss of crypto assets | $7.1K | ||
| Impairment loss of prepayments | $513.3K | $0 | $117.0K |
| Impairment loss of long-lived assets | $0 | $0 | $6.5M |
| Impairment loss of long-term investment | $2.4M | ||
| Share compensation expense | $73.2K | ||
| Issuance costs and amortization of discounts on convertible debentures | $1.1M | $1.2M | $1.1M |
| Change in fair value of convertible debentures | -$902.1K | ||
| Interest paid on convertible debentures recorded at fair value | -$613.5K | ||
| Interest expense of convertible debenture | $681.9K | $587.2K | |
| Interest expense of third party loans | $8.5K | ||
| Loss on warrants settlement | $1.9M | ||
| Crypto assets | $426.2K | -$2.7M | |
| Other receivables | -$112.0K | $655.6K | -$3.0M |
| Prepayments | -$310.0K | -$533.7K | $205.3K |
| Security deposits | $660.6K | ||
| Accounts payable | -$667.9K | ||
| Other payables and accrued liabilities | $185.0K | -$19.5K | $1.3M |
| Net cash used in operating activities | -$2.9M | -$2.3M | -$7.9M |
| Proceeds from sale of crypto assets | $4.7M | ||
| Advance for a long-term investment | -$200.0K | ||
| Loan to a third party | -$3.6M | ||
| Repayments from loans to third parties | $1.5M | ||
| Proceeds from investment of subsidiaries' noncontrolling interests | $250 | ||
| Net cash (used in) provided by investing activities | -$200.0K | $1.5M | $1.0M |
| Proceeds from issuance of ordinary shares through private offerings | $4.0M | ||
| Purchase of crypto assets to pay offering expenses | -$645.6K | ||
| Repayments to third party loans | -$819.0K | ||
| Payments of convertible debenture interest expense | -$608.7K | -$587.2K | |
| Payments of third party loans interest expense | -$8.5K | ||
| Proceeds from convertible debentures, net of issuance costs | $6.4M | $6.1M | |
| Repayments of convertible debenture | -$1.6M | ||
| Proceeds from exercise of warrants | $1.2M | ||
| Payment of equity issuance costs | -$1.2M | ||
| Net cash provided by (used in) financing activities | $4.6M | -$608.7K | $8.3M |
| CHANGES IN CASH AND CASH EQUIVALENTS | $1.5M | -$1.4M | $1.4M |
| Cash paid for interest | $613.5K | $608.7K | $270.2K |
| Conversion of convertible debenture into Class A Ordinary Shares | $4.9M | $6.3M | |
| Conversion of convertible debenture interest payable into Class A Ordinary Shares | $126.4K | $292.7K | |
| Exchange of warrants for convertible debenture | $2.0M | ||
| Exchange of pre-funded warrants for loans receivable | $10.0M | ||
| Issuance of convertible debenture in exchange for crypto assets | $5.1M | ||
| Issuance of Class A Ordinary Shares with redemption rights in exchange for crypto assets | $6.0M | ||
| Deemed dividend attributable to down round feature of warrants | $9.6M | $2.1M |
No quarter-by-quarter statement was filed.
Corporate structure
SANGRIX INC. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of SANGRIX INC.
- Jinghai Jiang Filed SCHEDULE 13D on SANGRIX INC., latest Feb 10, 2025
- SANGRIX INC. E9
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What SANGRIX INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Investments
Leadership
Who has led SANGRIX INC., and when. Pick a name to see everywhere that person has worked.
Chief executive
- Chief executive officerJinghai Jiang Aug 26, 2026 to now11
Board members and other officers (3)
- Board memberSiyuan Zhuang Mar 20, 2026 to now12
- Board memberXiaping Cao Mar 20, 2026 to now13
- Board memberMei Ting Yeung Aug 26, 2026 to now14
Named in SEC Form D filings
People the company listed in its private-offering notices.
- Executive Officer, DirectorLucas Wang named Oct 31, 2022 to Dec 22, 202315
- Executive OfficerXia Wang named Oct 31, 2022 to Dec 22, 202315
- Executive Officer, DirectorErick Rengifo named Oct 31, 202216
- Executive OfficerJiaming Li named Oct 31, 202216
- Executive OfficerLianfei Du named Oct 31, 202216
- DirectorYeung Mei Yu named Jun 12, 202417
- DirectorK.Bryce Toussaint named Oct 31, 2022 to Dec 22, 202315
- DirectorScott Silverman named Oct 31, 2022 to Dec 22, 202315
Former names
Timeline
- Aug 26, 2026New chief executive Jinghai Jiang becomes CEO11
Filings
172 filings to the SEC since October 2021: 6 annual reports, 6 insider forms, 1 large holders, 3 private raises, 156 other. The latest 20:
- Sep 23, 20266-K EDGAR
- Sep 18, 202620-F EDGAR
- Sep 18, 20266-K/A EDGAR
- Sep 15, 20266-K EDGAR
- Sep 10, 20263 OWNERSHIP DOCUMENT EDGAR
- Sep 9, 20266-K EDGAR
- Sep 3, 20266-K EDGAR
- Aug 26, 20263 OWNERSHIP DOCUMENT EDGAR
- Aug 26, 20263 OWNERSHIP DOCUMENT EDGAR
- Aug 21, 20266-K EDGAR
- Aug 12, 20266-K EDGAR
- Aug 6, 20266-K EDGAR
- Aug 6, 20266-K/A EDGAR
- Jul 31, 20266-K EDGAR
- Jul 28, 20266-K EDGAR
- Jul 14, 20266-K EDGAR
- Jul 9, 20266-K EDGAR
- Jul 1, 20266-K EDGAR
- Jun 30, 20266-K EDGAR
- Jun 29, 20266-K EDGAR
The 172 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Jinghai JiangSCHEDULE 13D, 1 filing Feb 10, 202518
Funding
Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.
- Private raises (Form D) $10.1M
Figures by year
| Year | Private raises (Form D) | Total |
|---|---|---|
| 2024 | $2.0M | $2.0M |
| 2023 | $6.1M | $6.1M |
| 2022 | $2.0M | $2.0M |
Private raises
Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.
SEC filer profile
How SANGRIX INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARSANGRIX INC.1
- CIK0001735556
- Filer statusNon-accelerated filer not an emerging growth company; not a shell company4
- Incorporated inCayman Islands4
- Fiscal year endsJune 301
- Industry code (SIC)6199 Finance Services1
- SEC reviewing officeOffice of Crypto Assets, Division of Corporation Finance1
- Business address160 Robinson Road, 12F, Sbf Center, Singapore, 068914, Singapore1
- Phone347-556-47471
- Shares outstanding733,246 Common Class A shares; 13,796 Common Class B shares as of Jun 30, 20264
- AuditorHTL International, LLC, Houston, Texas PCAOB ID 70004
- On EDGAR sinceMar 26, 20181
- Filings272 in all: 6-K (150), CORRESP (20), UPLOAD (15), 20-F (8), EFFECT (7), F-3/A (7), 144 (6), 3 (6)1
All 30 form types
D (6), F-3 (5), 424B5 (4), D/A (4), F-1 (4), F-1/A (4), NT 20-F (4), 424B4 (3), 6-K/A (3), FWP (2), POS AM (2), SEC STAFF ACTION (2), 144/A (1), 8-A12B (1), CERT (1), DRS (1), DRS/A (1), DRSLTR (1), RW (1), SC 13G (1), SC 13G/A (1), SCHEDULE 13D (1)
- Latest filingsAnnual report (20-F) Sep 18, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| SGRX | Nasdaq |
From the cover page of the 20-F filed Sep 18, 2026 (Section 12(b) of the Exchange Act).4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARSANGRIX INC. filings on SEC EDGAR
- 2SEC EDGARSANGRIX INC. 10-K for fiscal 2026
- 3SEC EDGARSANGRIX INC. filings on SEC EDGAR
- 4
- 5SEC EDGARSANGRIX INC. 10-K for fiscal 2019
- 6SEC EDGARSANGRIX INC. 10-K for fiscal 2020
- 7SEC EDGARSANGRIX INC. 10-K for fiscal 2022
- 8SEC EDGARSANGRIX INC. 10-K for fiscal 2023
- 9SEC EDGARSANGRIX INC. 10-K for fiscal 2020
- 10SEC EDGARSANGRIX INC. 10-K for fiscal 2021
- 11
- 12SEC EDGARSiyuan Zhuang, Board member
- 13SEC EDGARXiaping Cao, Board member
- 14SEC EDGARMei Ting Yeung, Board member
- 15
- 16
- 17
- 18